By applying internal capabilities and exploiting funds from national and European Grants, C4T has driven proprietary early discovery projects and gained expertise in specific research areas. Hit identification and Hit to Lead programs are performed in tight collaboration with Academia partners in charge of projects molecular biology.
||CBR Drug Discovery Platform
||Original Focused library of PIM-1 Inhibitors (Unpublished data)
(MMP-2 and MMP-9)
|Original Focused libraries of MMPs inhibitors|
New class of Tγδ linfocytes activators ( J.Med.Chem. 2009)